Limitations of VS38c labeling in the detection of plasma cell myeloma by flow cytometry

被引:2
|
作者
Czeti, Agnes [1 ]
Szaloki, Gabor [1 ]
Varga, Gergely [2 ]
Szita, Virag Reka [2 ]
Komlosi, Zsolt Istvan [3 ]
Takacs, Ferenc [1 ]
Mark, Agnes [1 ]
Timar, Botond [1 ]
Matolcsy, Andras [1 ]
Barna, Gabor [1 ]
机构
[1] Semmelweis Univ, Fac Med, Dept Pathol & Expt Canc Res 1, Ulloi Ut 26, Budapest, Hungary
[2] Semmelweis Univ, Dept Internal Med & Haematol, Fac Med, Budapest, Hungary
[3] Semmelweis Univ, Fac Med, Dept Genet Cell & Immunobiol, Budapest, Hungary
关键词
CLIMP-63; flow cytometry; immunophenotyping; intracellular labeling; plasma cell myeloma; VS38c; MINIMAL RESIDUAL DISEASE; MULTIPLE-MYELOMA; MONOCLONAL-ANTIBODY; EXPRESSION; MEMBRANES; PERMEABILIZATION; RESISTANCE; BLOOD; CD38;
D O I
10.1002/cyto.a.24488
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Plasma cell myeloma (multiple myeloma [MM]) is a malignant neoplasm originating from the plasma cells. Besides other methods, flow cytometric analysis of the patient's bone marrow aspirate has an important role in the diagnosis and also in the response assessment. Since the cell surface markers, used for identifying abnormal plasma cells, are expressed diversely and the treatment can also alter the phenotype of the plasma cells, there is an increasing demand for new plasma cell markers. VS38c is a monoclonal antibody that recognizes the CLIMP-63 protein in the membrane of the endoplasmic reticulum. CLIMP-63 is known to be expressed at high levels in normal and pathologic plasma cells in the bone marrow, thus VS38c antibody can be used to identify them. Although VS38c staining of plasma cells is reported to be constant and strong even in myeloma, we were wondering whether sample preparation can affect the staining. We have investigated the effect of different permeabilization agents and washing of the cells on the quality of the VS38c staining and found that in many cases the staining is inadequate to identify the plasma cells. We measured the VS38c staining of the bone marrow aspirates of 196 MM patients and observed that almost all cases showed bright staining with VS38c. However, permeabilization with mild detergent resulted in the appearance of a significant VS38c(dim) subpopulation, which showed increased sensitivity to mechanical stress (centrifugation). Our results indicate that VS38c(dim) MM cells can appear due to the improper permeabilization of the endoplasmic reticulum and this finding raises the possibility of the existence of a plasma cell subpopulation with different membrane properties. The significance of this population is unclear yet, but these cells can be easily missed with VS38c staining and can be lost due to centrifugation-induced lysis during sample preparation.
引用
收藏
页码:159 / 166
页数:8
相关论文
共 50 条
  • [21] Potential Therapeutic Targets in Plasma Cell Disorders: A Flow Cytometry Study
    Lisenko, Katharina
    Schoenland, Stefan
    Hegenbart, Ute
    Wallenwein, Katrin
    Braun, Ute
    Mai, Elias K.
    Hillengass, Jens
    Goldschmidt, Hartmut
    Jauch, Anna
    Ho, Anthony D.
    Raab, Marc
    Hundemer, Michael
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2017, 92 (02) : 145 - 152
  • [22] VS38 Identifies Myeloma Cells With Dim CD38 Expression and Plasma Cells Following Daratumumab Therapy, Which Interferes With CD38 Detection for 4 to 6 Months
    Courville, Elizabeth L.
    Yohe, Sophia
    Shivers, Paula
    Linden, Michael A.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 153 (02) : 221 - 228
  • [23] Cell Labeling Approaches for Fluorescence-Based In Vivo Flow Cytometry
    Pitsillides, Costas M.
    Runnels, Judith M.
    Spencer, Joel A.
    Zhi, Liang
    Wu, Mei X.
    Lin, Charles P.
    CYTOMETRY PART A, 2011, 79A (10) : 758 - 765
  • [24] Immunohistological analysis in diagnosis of plasma cell myeloma based on cytoplasmic kappa/lambda ratio of CD38-positive plasma cells
    Nakayama, Shoko
    Yokote, Taiji
    Hirata, Yuji
    Iwaki, Kazuki
    Akioka, Toshikazu
    Miyoshi, Takuji
    Nishiwaki, Uta
    Masuda, Yuki
    Hiraoka, Nobuya
    Takayama, Ayami
    Nishimura, Yasuichiro
    Tsuji, Motomu
    Hanafusa, Toshiaki
    HEMATOLOGY, 2012, 17 (06) : 317 - 320
  • [25] VS38 as a promising CD38 substitute antibody for flow cytometric detection of plasma cells in the daratumumab era
    Shumpei Mizuta
    Takahito Kawata
    Hiroshi Kawabata
    Noriko Yamane
    Saya Mononobe
    Takao Komai
    Yusuke Koba
    Naoya Ukyo
    Akira Tamekane
    Mitsumasa Watanabe
    International Journal of Hematology, 2019, 110 : 322 - 330
  • [26] Polychromatic Flow Cytometry is More Sensitive than Microscopy in Detecting Small Monoclonal Plasma Cell Populations
    Tran, Daniel N.
    Smith, Sandy A. B. C.
    Brown, David A.
    Parker, Andrew J. C.
    Joseph, Joanne E.
    Armstrong, Nicola
    Sewell, William A.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2017, 92 (02) : 136 - 144
  • [27] Immunophenotypic Characterization and Quantification of Neoplastic Bone Marrow Plasma Cells by Multiparametric Flow Cytometry and Its Clinical Significance in Korean Myeloma Patients
    Cho, Young-Uk
    Park, Chan-Jeoung
    Park, Seo-Jin
    Chi, Hyun-Sook
    Jang, Seongsoo
    Park, Sang Hyuk
    Seo, Eul-Ju
    Yoon, Dok Hyun
    Lee, Jung-Hee
    Suh, Cheolwon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2013, 28 (04) : 542 - 549
  • [28] Aggressive and extramedullary plasma cell myeloma evade bone marrow flow cytometric minimal residual disease detection
    Came, Neil
    Vuong Nguyen
    Westerman, David
    Harrison, Simon
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 (06) : 947 - 949
  • [29] FLOCK cluster analysis of plasma cell flow cytometry data predicts bone marrow involvement by plasma cell neoplasia
    Dorfman, David M.
    LaPlante, Charlotte D.
    Li, Betty
    LEUKEMIA RESEARCH, 2016, 48 : 40 - 45
  • [30] Correlation of assessment of plasma cells by flow cytometry and detection of cytogenomic abnormalities by fluorescence in situ hybridization in plasma cell neoplasms
    Lu, G.
    Zhang, X. X.
    You, M. J.
    Chen, W.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2011, 33 (05) : 545 - 550